Funding
Funding for the PRIMORDIAL study is from Medical Research Council, UK (MR/R020345/1) the Global Challenges Research fund, University of Oxford, UK (0006138), and Newton Fund (BT/IN/DBT-MRC/DIFD/JM/12/2018–19).